tiprankstipranks
Trending News
More News >
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (HK:2502)
:2502
Hong Kong Market
Advertisement

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) AI Stock Analysis

Compare
0 Followers

Top Page

HK:2502

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H

(2502)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 4o)
Rating:52Neutral
Price Target:
HK$0.50
▲(16.28% Upside)
The overall stock score of 52 reflects mixed financial performance with positive revenue growth but declining profitability and net income. Technical analysis indicates bearish momentum, while valuation is challenged by a negative P/E ratio despite a high dividend yield. The absence of earnings call data and corporate events limits further insights.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) vs. iShares MSCI Hong Kong ETF (EWH)

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Business Overview & Revenue Model

Company DescriptionHenan Jinyuan Hydrogenated Chemicals Co., Ltd. engages in the processing, production, distribution, and sale of hydrogenated benzene-based chemicals and energy products in the People's Republic of China. Its hydrogenated benzene-based chemicals include pure benzene, toluene, and xylene; and energy products comprising liquefied natural gas (LNG) and coal gas. The company is also involved in the trading and retail of LNG and oil products; operation of oil and gas stations; steam services; and provision of multimodal transportation, warehousing, and distribution services for coal products. It serves nylon and fertilizers manufacturers, refined oil manufacturers, and other chemical companies, as well as industrial users, and trading and retail customers. The company was incorporated in 2012 and is headquartered in Jiyuan, China. Henan Jinyuan Hydrogenated Chemicals Co., Ltd. operates as a subsidiary of Henan Jinma Energy Company Limited.
How the Company Makes MoneyHenan Jinyuan Hydrogenated Chemicals Co., Ltd. generates revenue primarily through the sale of its hydrogenated chemical products. The company's key revenue streams include direct sales to industrial clients in sectors like pharmaceuticals and agrochemicals, as well as distribution partnerships that help expand its market reach. Additionally, Henan Jinyuan may engage in strategic collaborations or joint ventures to enhance its product offerings and access new markets, thereby contributing to its earnings.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Financial Statement Overview

Summary
The company is struggling with profitability and growth consistency. Despite some revenue recovery, profitability margins have worsened, leading to net losses. The balance sheet shows moderate stability but with increased leverage, and cash flow management has improved but remains inconsistent.
Income Statement
55
Neutral
The company has experienced significant volatility in revenue and profitability. The gross profit margin has declined from 12.4% in 2021 to 2.3% in 2024, indicating pressure on cost management. The net profit margin has deteriorated from 4.1% to negative, reflecting net losses in 2024. Revenue growth has been inconsistent, with a decrease of 10.4% from 2022 to 2023, followed by a 33.1% increase in 2024, but this did not translate to profitability. EBIT and EBITDA margins have also fallen, indicating operational inefficiencies.
Balance Sheet
65
Positive
The balance sheet shows moderate financial stability with a debt-to-equity ratio of 0.34 in 2024, up from 0.22 in 2020, indicating increased leverage. The return on equity has turned negative in 2024, reflecting net losses. However, the equity ratio remains strong at 58.8% in 2024, suggesting a solid asset base supported by equity.
Cash Flow
60
Neutral
Cash flow performance has been mixed. Free cash flow turned positive in 2024, but overall growth has been inconsistent. The operating cash flow to net income ratio shows cash generation issues with net income losses. The free cash flow to net income ratio improved in 2024, indicating better cash management despite net losses.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.10B2.33B2.30B1.46B1.02B
Gross Profit71.64M148.80M285.51M142.80M91.41M
EBITDA77.03M163.47M266.82M176.34M113.14M
Net Income-16.04M54.92M121.38M59.14M24.48M
Balance Sheet
Total Assets1.68B1.66B1.06B971.94M969.90M
Cash, Cash Equivalents and Short-Term Investments352.62M300.71M106.16M73.03M78.34M
Total Debt338.27M262.97M219.16M96.89M125.83M
Total Liabilities584.85M535.95M334.98M400.14M447.76M
Stockholders Equity985.37M1.02B573.79M457.93M400.56M
Cash Flow
Free Cash Flow13.82M-43.95M199.74M44.27M-21.69M
Operating Cash Flow96.86M104.46M318.82M94.88M50.62M
Investing Cash Flow-268.86M-71.06M-150.12M-59.21M-72.31M
Financing Cash Flow2.49M204.95M-133.45M-40.95M20.11M

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.43
Price Trends
50DMA
0.50
Negative
100DMA
0.44
Positive
200DMA
0.42
Positive
Market Momentum
MACD
-0.02
Positive
RSI
36.19
Neutral
STOCH
38.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2502, the sentiment is Negative. The current price of 0.43 is below the 20-day moving average (MA) of 0.48, below the 50-day MA of 0.50, and above the 200-day MA of 0.42, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 36.19 is Neutral, neither overbought nor oversold. The STOCH value of 38.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2502.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
1.02B8.042.56%8.24%-5.37%25.20%
68
Neutral
218.40M12.500.00%2.20%29.04%-1.55%
52
Neutral
7.33-6.64%4.94%2.76%-293.57%
52
Neutral
771.20M-26.58-1.20%5.41%0.37%-331.54%
48
Neutral
616.30M-17.73-9.30%0.35%-153.95%
41
Neutral
62.77M-0.0516.58%-15.10%31.07%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2502
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
0.43
-0.15
-25.86%
YIPCF
Yip's Chemical Holdings
0.20
0.03
17.65%
HK:1986
Tsaker New Energy Tech Co., Limited
0.80
0.05
6.67%
HK:2116
Jiangsu Innovative Ecological New Materials Ltd.
0.46
0.08
21.05%
HK:0301
SANVO Fine Chemicals Group Limited
1.31
0.53
67.95%
HK:0377
China Huajun Group Limited
1.02
0.35
52.24%

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Corporate Events

Henan Jinyuan Reports Interim Loss Amidst Revenue Decline
Aug 26, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. reported its interim financial results for the first half of 2025, showing a revenue of RMB1,442.2 million and a loss attributable to owners of RMB20.2 million. The company experienced a decline in gross profit and a net loss for the period, indicating challenges in maintaining profitability amidst market conditions.

The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.

Henan Jinyuan Settles Taxes and Reduces Non-Aromatic Hydrocarbon Sales
Aug 8, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced that it has settled all relevant consumption taxes with the tax authorities by the end of June 2025, which were already accounted for in its 2024 financial results. Consequently, there is no financial impact on the company’s results for the first half of 2025. The company has significantly reduced its production and sales of non-aromatic hydrocarbons in the first half of 2025, anticipating a decrease in sales for the entire year compared to 2024, thus minimizing the financial impact of the consumption tax.

Henan Jinyuan Issues Profit Warning Amidst Declining Margins
Aug 8, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has issued a profit warning, indicating an expected loss of approximately RMB20.1 million for the first half of 2025. This downturn is attributed to a reduction in the gross profit margin of its main product, hydrogenated benzene-based chemicals, due to a price decrease that outpaced the reduction in raw material costs. The company advises caution for shareholders and potential investors as the financial results are yet to be finalized and audited.

Henan Jinyuan Hydrogenated Chemicals Announces Upcoming Board Meeting
Aug 8, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has announced a board meeting scheduled for August 26, 2025, to discuss and potentially approve the unaudited interim results for the first half of 2025 and consider the payment of an interim dividend. This meeting could have significant implications for the company’s financial performance and shareholder returns, as it will address key financial results and potential dividend distributions.

Henan Jinyuan Confirms No Change in Controlling Shareholder
Aug 5, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced that there is no change in the shareholding of its controlling shareholder, Jinma Energy. Despite a termination notice served by Jinma Coking to Beijing Weigang regarding the sale of shares, Jinma Energy remains under the control of Mr. Yiu. This development is not expected to have any material impact on the financial position or operations of the company.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 09, 2025